Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

X Tian, C Li, A Huang, S Xia, S Lu, Z Shi… - Emerging microbes & …, 2020 - Taylor & Francis
… -nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-SARS CoV antibodies
with 2019-nCoV … Human monoclonal antibody combination against SARS coronavirus: …

[HTML][HTML] Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay

E Lopez, ER Haycroft, A Adair, FL Mordant, MT O'Neill… - JCI insight, 2021 - ncbi.nlm.nih.gov
… Here, we used a bead-based multiplex assay to evaluate the neutralizing capacity of
SARS-CoV-2 antibodies against recombinant RBD variants. This was achieved by coupling each …

B. 1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

H Zhou, BM Dcosta, MI Samanovic, MJ Mulligan… - MBio, 2021 - Am Soc Microbiol
… elicited antibodies neutralized the B.1.526 variant. One of the Regeneron therapeutic …
antibodies was less effective against the B.1.526 (E484K) variant but the two-antibody combination

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection

A Zhang, HD Stacey, MR D'Agostino, Y Tugg… - Nature Reviews …, 2023 - nature.com
… , including antibody isotype–Fc receptor combinations, Fc receptor-bearing cell types and
… how these properties influence antibody function in the context of SARS-CoV-2 infection. …

[HTML][HTML] Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing

PU Fischer, K Fischer, KC Curtis, Y Huang… - The American Journal …, 2021 - ncbi.nlm.nih.gov
… The primary objectives of the study were to assess the sensitivity and specificity of tests for
antibodies to SARS-CoV-2 proteins, and the kinetics of antibody responses relative to the time …

Determinants of passive antibody efficacy in SARS-CoV-2 infection

E Stadler, KL Chai, TE Schlub, D Cromer… - MedRxiv, 2022 - medrxiv.org
… effectiveness of SARS-CoV-2-specific neutralising monoclonal antibodies, hyperimmune …
participants with or without potential exposure to SARS-CoV-2. The RCTs were identified from …

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs… - Elife, 2021 - elifesciences.org
… binding SARS- CoV- 2 spike by combining in vivo antibody … spike nanobodies and their
combinations by complementary … This work thus provides significant impacts on SARS- CoV- 2 …

[HTML][HTML] Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

F Muecksch, Y Weisblum, CO Barnes, F Schmidt… - Immunity, 2021 - cell.com
… -coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from
… In addition to increased affinity and neutralization potency, antibody evolution changed the …

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections

H Lv, NC Wu, OTY Tsang, M Yuan, RAPM Perera… - Cell reports, 2020 - cell.com
… the antibody response to SARS-CoV-2 and SARS-CoV … -reactivity of antibody responses to
SARS-CoV-2 and SARS-CoV in … monoclonal antibody combination against SARS coronavirus

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection

J Pušnik, WO Monzon-Posadas, J Zorn… - Nature …, 2023 - nature.com
… To investigate whether the same pattern can be observed for only neutralizing antibodies
we performed plaque reduction assays using live unmanipulated SARS-CoV-2 isolates: wild-…